2-47478309-T-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7

The NM_000251.3(MSH2):​c.2248T>C​(p.Leu750Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,614,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L750L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000055 ( 0 hom. )

Consequence

MSH2
NM_000251.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.08

Publications

1 publications found
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MSH2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet
  • Lynch syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 2-47478309-T-C is Benign according to our data. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-47478309-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 219939.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.08 with no splicing effect.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MSH2NM_000251.3 linkc.2248T>C p.Leu750Leu synonymous_variant Exon 14 of 16 ENST00000233146.7 NP_000242.1 P43246-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MSH2ENST00000233146.7 linkc.2248T>C p.Leu750Leu synonymous_variant Exon 14 of 16 1 NM_000251.3 ENSP00000233146.2 P43246-1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152228
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000239
AC:
6
AN:
251402
AF XY:
0.0000442
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000879
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000547
AC:
8
AN:
1461760
Hom.:
0
Cov.:
32
AF XY:
0.00000963
AC XY:
7
AN XY:
727164
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39680
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86250
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53402
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000180
AC:
2
AN:
1111932
Other (OTH)
AF:
0.00
AC:
0
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152346
Hom.:
0
Cov.:
31
AF XY:
0.0000268
AC XY:
2
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41578
American (AMR)
AF:
0.00
AC:
0
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Benign:2
Jun 28, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Feb 13, 2017
Color Diagnostics, LLC DBA Color Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Lynch syndrome 1 Benign:1
Dec 12, 2024
Myriad Genetics, Inc.
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. -

Lynch syndrome Benign:1
Oct 06, 2023
All of Us Research Program, National Institutes of Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Mar 30, 2017
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: The MSH2 c.2248T>C (p.Leu750Leu) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. One in silico tool predicts a damaging outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. ESE finder predicts that this variant does not significantly affect ESE sites at the locus. However, these predictions have yet to be confirmed by functional studies. This variant was found in the large control database ExAC in 6 of 121332 control chromosomes, predominantly observed in the South Asian subpopulation at a frequency of 0.000303 (5/16500). This frequency is nearly equivalent to the estimated maximal expected allele frequency of a pathogenic MSH2 variant (0.0005683), suggesting this is may be a benign polymorphism found primarily in the populations of South Asian origin. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as likely benign. To our knowledge, the variant of interest has not been reported in affected individuals via publications, nor has it been evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as likely benign. -

Hereditary nonpolyposis colorectal neoplasms Benign:1
Dec 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Muir-Torré syndrome;C2936783:Lynch syndrome 1;C5436806:Mismatch repair cancer syndrome 2 Benign:1
Dec 19, 2024
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.68
CADD
Benign
6.4
DANN
Benign
0.71
PhyloP100
1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs527725593; hg19: chr2-47705448; COSMIC: COSV99254667; API